SELECT LANGUAGE BELOW

Kratos and CVS Health receive upgrades: Leading analyst recommendations

Kratos and CVS Health receive upgrades: Leading analyst recommendations

The latest buzz in Wall Street research seems to center around a few key companies. Here’s a rundown of today’s highlighted research calls that investors might want to pay attention to: Top 5 Upgrades: Baird has upgraded CVS Health (CVS) from neutral to outperform, raising its price target from $71 to $82. The company is […]